Historical perspectives in the development of antiviral agents against poxviruses.

Abstract

The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were identified. This dates back to 1950; and, although there is at present no single antiviral drug specifically licensed for the chemotherapy or -prophylaxis of poxvirus infections, numerous candidate compounds have been described over the past 50 years. These compounds include interferon and inducers thereof (i.e., polyacrylic acid), 5-substituted 2'-deoxyuridines (i.e., idoxuridine), IMP dehydrogenase inhibitors, S-adenosylhomocysteine hydrolase inhibitors, acyclic nucleoside phosphonates (such as cidofovir) and alkoxyalkyl prodrugs thereof (such as CMX001), viral egress inhibitors (such as tecovirimat), and cellular kinase inhibitors (such as imatinib).

• Authors: Erik De Clercq
• Journal: Viruses (Viruses) Vol. 2 Issue 6 Pg. 1322-1339 (Jun 2010) ISSN: 1999-4915 [Electronic] Switzerland
• PMID: 21994682 (Publication Type: Journal Article)